Viewing Study NCT03445858


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2025-12-25 @ 10:24 PM
Study NCT ID: NCT03445858
Status: COMPLETED
Last Update Posted: 2024-07-10
First Post: 2018-02-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults
Sponsor: Children's Hospital Medical Center, Cincinnati
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-02-12
Start Date Type: ACTUAL
Primary Completion Date: 2023-11-07
Primary Completion Date Type: ACTUAL
Completion Date: 2023-11-07
Completion Date Type: ACTUAL
First Submit Date: 2018-02-14
First Submit QC Date: None
Study First Post Date: 2018-02-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-09
Last Update Post Date: 2024-07-10
Last Update Post Date Type: ACTUAL